Kentera 3.9 mg / 24 hours transdermal patch

Licence status
Authorised: 12/08/2004
Active substances
Oxybutynin
Dosage Form
Transdermal patch
Licence number
EU/1/03/270/1-2
Licence holder
Teva B.V.

Product documents

Licence information

ATC code
G04BD Drugs for urinary frequency and incontinence, G04BD04 oxybutynin
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
12/08/2004